
Top medtech trends to watch in 2026
From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech Dive’s roundup of the top medtech trends to watch in 2026.

From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech Dive’s roundup of the top medtech trends to watch in 2026.

Imperative Care announced the launch of the new Zoom 4S thrombectomy catheter and reported the first patient cases with the device.

Olympus today announced the U.S. launch of its most advanced single-use fine needle biopsy device.

“The Maestro combines advanced functionality with more sustainable design and electronic integration, making it ideal for today’s clinical and home healthcare applications,” said Eric Saks.

RAMAT GAN, Israel, Jan. 26, 2026 /PRNewswire/ — Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a global leader in connected home ultrasound technology, today announced an additional strategic commercial agreement with Clalit Health Services, Israel’s largest health maintenance organization (HMO), to supply Pulsenmore FC, a new at-home ultrasound solution designed for remote follicular monitoring in women undergoing fertility care (IVF and fertility preservation).

Penumbra (NYSE:PEN) announced today that it launched the Lightning Flash 3.0 computer-assisted vacuum thrombectomy (CAVT) system.

BELLEVUE, Wash., Jan. 22, 2026 /PRNewswire/ — Woori IO, an OSR company developing next-generation noninvasive glucose monitoring technologies, today commented on the U.S. Food and Drug Administration’s recent clarification regarding non-medical-grade wearable devices, noting that the FDA’s position establishes a regulatory framework highly conducive to Woori IO’s commercialization strategy.

Zimmer Biomet (NYSE: ZBH)+
recently announced the Brachiator mini-rail external fixation system.

The project began at the University of Pittsburgh’s Makerspace during the Pitt Challenge Healthcare Hackathon in 2021 and has since grown into a community driven effort.

Johnson & Johnson (NYSE: JNJ)+
announced that it launched the Arbrea Breast Simulator Surgeon App for Mentor in the U.S.